carbamates has been researched along with Malignant Carcinoid Syndrome in 1 studies
Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HONET, JC | 1 |
| CASEY, TV | 1 |
| RUNYAN, JW | 1 |
1 other study available for carbamates and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
False-positive urinary test for 5-hydroxyindoleacetic acid due to methocarbamol and mephenesin carbamate.
Topics: Carbamates; Hydroxyindoleacetic Acid; Indoleacetic Acids; Malignant Carcinoid Syndrome; Mephenesin; | 1959 |